Showing results (1-10 of 413) with videos related to

Sort By:
Pageof 42
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2005
Cardiovascular risk of selective cyclooxygenase-2 inhibitorsKarsten Schrör, Paulette Mehta, Jawahar L Mehta
The American Journal of Cardiology|January 8, 2011
Change in mortality from coronary heart disease and stroke in Arkansas (1979 to 2007)Appathurai Balamurugan, Paulette Mehta, Joseph Bates, et al.
Endothelium : Journal of Endothelial Cell Research|April 18, 2003
Potential anticancer effects of statins: fact or fiction?Varsha Kaushal, Manish Kohli, Paulette Mehta, et al.
The American Journal of Cardiology|March 30, 2010
Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs HospitalsJawahar L Mehta, Zoran Bursac, Paulette Mehta, et al.
Physiological Genomics|March 25, 2010
Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient miceBum-Yong Kang, Changping Hu, Sunhyo Ryu, et al.
Cardiovascular Drugs and Therapy|August 18, 2011
LOX-1: a critical player in the genesis and progression of myocardial ischemiaJingjun Lü, Jawahar L Mehta
Current Opinion in Cardiology|September 1, 2007
Lessons from hormone replacement therapy trials for primary prevention of cardiovascular diseaseBhavna Mohandas, Jawahar L Mehta
World Journal of Cardiology|December 17, 2010
Aspirin resistance: Fact or fiction? A point of viewJawahar L Mehta, Bhavna Mohandas
Pageof 42